Palantir has £330m in NHS contracts. Should Britain be worried?
A US defence and surveillance company has quietly become one of the biggest tech suppliers to the British state. Here is what that means for patients, taxpayers and public data.
Key points
- Palantir, a US defence and data-analytics company, holds a £330 million contract with the NHS in England.
- Parliament's science, innovation and technology committee said in 2024 that the government should end its relationship with Palantir, citing a "clear mismatch with UK values".
- Peter Thiel and Alex Karp co-founded Palantir; the company built its name on surveillance and intelligence contracts with the US military and security agencies.
- Andy Burnham, tipped as a future Labour leadership candidate, faces pressure from colleagues to review British public contracts with the company.
- Defenders of the deal, including former Conservative adviser Camilla Cavendish writing in the Financial Times, argue the only test that matters is whether the technology works.
Palantir isn't a household name. But if you've used the NHS recently, this company probably touched your data.
Founded by billionaire Peter Thiel and chief executive Alex Karp, it built its fortune selling data-analysis software to the US military and intelligence agencies. That software aggregates vast volumes of information and surfaces patterns. Palantir is now one of the largest technology suppliers to the British state, with contracts across defence, immigration and policing.
The biggest is a £330 million deal with NHS England. That public money buys Palantir's Federated Data Platform, a system that pulls patient records from different hospitals into a single view for doctors and managers. The practical goal is reasonable: cut waiting lists by making information flow faster.
Critics point to two things. First, who Palantir is. Its tools have been used to track migrants, target military strikes and monitor protesters. Parliament's own science, innovation and technology committee warned last year that Palantir's track record represents a "clear mismatch with UK values".
Second, how the contracts were won. Investigative reporting, including work by Peter Geoghegan published in The Guardian, suggests paid-for political access helped Palantir embed itself in Whitehall before strong procurement rules were in place.
Should NHS patients be worried about their data?
The NHS says data inside the platform stays under NHS control and can't be sold or shared with Palantir's other clients. Independent experts acknowledge the contractual protections are real but argue oversight is thin. A sale, a sanction or a serious breach could test those protections hard.
Your GP records aren't currently inside the platform. Hospital operational data, bed availability, waiting times, make up most of what flows through it.
The political pressure is growing. Several Labour MPs want the contract reviewed. The counterargument, made plainly in the Financial Times by Cavendish, is blunt: if it cuts waiting lists, use it. Both positions deserve a hearing. The technology may work. Working well and being the right long-term partner for a public health system are different questions, and Britain hasn't seriously asked the second one yet.
AI2Day first covered the intersection of Peter Thiel's ventures and public policy on 15 July 2026; this is the most consequential context that reporting has led us to.
The plain judgement here is that the contract probably delivers real operational value, but the oversight framework is nowhere near strong enough for a deal of this sensitivity. Watch whether Burnham orders an independent audit or quietly lets the contract run.
What you can do now: if you want to know what data the NHS holds about you and how it's shared, request that information directly from your GP surgery or hospital trust under UK data protection law. It costs nothing and takes one letter.
